0001485003-19-000010.txt : 20190225
0001485003-19-000010.hdr.sgml : 20190225
20190225161120
ACCESSION NUMBER: 0001485003-19-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190221
FILED AS OF DATE: 20190225
DATE AS OF CHANGE: 20190225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cannell Thomas R
CENTRAL INDEX KEY: 0001637822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 19629586
MAIL ADDRESS:
STREET 1: C/O SESEN BIO, INC.
STREET 2: 245 FIRST STREET, SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sesen Bio, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
wf-form4_155112906509577.xml
FORM 4
X0306
4
2019-02-21
0
0001485003
Sesen Bio, Inc.
SESN
0001637822
Cannell Thomas R
C/O SESEN BIO, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Employee Stock Option (Right to Buy)
0.8285
2019-02-21
4
A
0
1000000
0
A
2029-02-21
Common Stock
1000000.0
1000000
D
On February 21, 2019, the reporting person was awarded options to purchase 1,000,000 shares of the common stock of Sesen Bio, Inc. (the "Company"), which options vest 6.25% every three months over four years provided the reporting person is employed by the Company at each such vesting date.
/s/ Richard F. Fitzgerald, Attorney-in-fact
2019-02-25